GICS Sector : Healthcare
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States.It operates through three segments: Care Partners, Care Delivery, and Care Enablement.The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Astrana Health delivered a robust third quarter in 2025, with total revenues reaching $956 million, representing a 100% year-over-year increase and a 46% sequential growth, largely driven by the integration of Prospect Health and solid organic growth. Adjusted EBITDA was $68.5 million, up 52% year-over-year and 42% sequentially. However, the company's EPS was $0.01, falling short of estimates at $0.47.
Publication Date: Nov -10
The company's operational performance was strong, with a focus on smart growth, disciplined risk progression, quality and cost excellence, and operating leverage through technology. Astrana is making significant progress in integrating Prospect Health, with a focus on aligning and enhancing the provider and patient experience, standardizing operating systems and financial reporting, and implementing Astrana's technology platform. As Brandon Sim noted, "the integration is going smoothly," and the company is on track to achieve its goals.
Astrana is leveraging AI across its enterprise to drive improvements in efficiency and care quality. The company's predictive models identify patients at high medical risk, and AI-driven tools are being deployed to reduce administrative friction and prevent fraud, waste, and abuse. The introduction of a large language model integrated into its platform is a significant step forward, allowing clinicians to query a patient's longitudinal medical record and receive cited source-based responses.
Astrana has updated its 2025 guidance, with total revenue expected to be in the range of $3.1 billion to $3.18 billion and adjusted EBITDA in the range of $200 million to $210 million. The update reflects the timing of full risk contracts with certain payer partners, which have shifted from a 2025 start to a first quarter 2026 start date. Analysts estimate next year's revenue growth at 27.4%, indicating a strong outlook for the company.
With a P/E Ratio of 121.0, P/B Ratio of 1.6, and EV/EBITDA of 17.87, Astrana's valuation metrics suggest that the market is pricing in significant growth expectations. The company's Net Debt / EBITDA ratio is -7.5, indicating a healthy debt position. The Free Cash Flow Yield is 7.36%, which is a positive sign for investors.
Geode Capital Management LLC Lowers Holdings in Astrana Health, Inc. $ASTH
Nov -29
Astrana Health, Inc. (ASTH) Q3 2025 Earnings Call Transcript
Nov -07
Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates
Nov -06
Astrana Health, Inc. Reports Third Quarter 2025 Results
Nov -06
Yousif Capital Management LLC Sells 2,309 Shares of Astrana Health, Inc. $ASTH
Oct -24
Astrana Health, Inc. Schedules 2025 Third Quarter Financial Results Release and Conference Call
Oct -15
Astrana Health, Inc. to Participate in Upcoming Investor Conferences
Sep -02
ASTH vs. USPH: Which Stock Is the Better Value Option?
Aug -29
Care Partners from Astrana Health, Inc. achieves 10% growth driven by increasing demand for value-based care, expansion into new markets, strategic partnerships, and investments in digital health technologies. Additionally, the company's focus on patient-centered care, cost-effective solutions, and strong provider networks contribute to its growth momentum.
Astrana Health's Care Delivery segment growth of 11% is driven by increasing adoption of value-based care models, expansion of Medicare Advantage and Medicaid managed care contracts, and strategic partnerships with healthcare providers to improve patient outcomes and reduce costs.
Astrana Health's Care Enablement segment growth of 13% is driven by increasing adoption of value-based care, rising demand for patient engagement platforms, and expansion into new markets. Additionally, the company's strategic partnerships, innovative care coordination solutions, and investments in AI-powered analytics are contributing to its rapid growth.
Astrana Health's 9% growth is driven by increasing demand for its innovative diagnostic solutions, strategic partnerships, and expansion into new markets. Additionally, the company's focus on digital health and AI-powered diagnostics has enabled it to capitalize on the growing trend of personalized medicine, further fueling its growth.
AstranaMD is a comprehensive telemedicine platform that enables remote consultations between patients and healthcare providers.
AstranaRx is a digital pharmacy platform that allows patients to manage their prescriptions and medications online.
AstranaCare is a care coordination platform that enables healthcare providers to manage patient care plans and coordinate care across different settings.
AstranaAnalytics is a data analytics platform that provides insights and analytics to healthcare providers and payers.
Astrana Health, Inc. has a moderate threat of substitutes due to the availability of alternative healthcare services and products.
Astrana Health, Inc. has a low bargaining power of customers due to the lack of concentration of buyers in the healthcare industry.
Astrana Health, Inc. has a moderate bargaining power of suppliers due to the presence of multiple suppliers in the healthcare industry.
Astrana Health, Inc. has a high threat of new entrants due to the growing demand for healthcare services and the ease of entry into the market.
Astrana Health, Inc. operates in a highly competitive industry with many established players, leading to a high intensity of rivalry.
| Value | |
|---|---|
| Debt Weight | 34.32% |
| Debt Cost | 7.79% |
| Equity Weight | 65.68% |
| Equity Cost | 9.52% |
| WACC | 8.93% |
| Leverage | 52.26% |
Value: 6.4
Growth: 3.7
Quality: 6.4
Yield: 8.0
Momentum: 1.5
Volatility: 2.7
1-Year Total Return ->
Value: 3.6
Growth: 7.8
Quality: 6.6
Yield: 0.0
Momentum: 3.0
Volatility: 7.3
1-Year Total Return ->
Value: 6.6
Growth: 6.2
Quality: 4.6
Yield: 0.0
Momentum: 7.5
Volatility: 3.3
1-Year Total Return ->
Value: 4.9
Growth: 6.4
Quality: 4.7
Yield: 0.0
Momentum: 9.5
Volatility: 1.0
1-Year Total Return ->
Value: 9.6
Growth: 4.6
Quality: 3.5
Yield: 0.0
Momentum: 1.0
Volatility: 4.0
1-Year Total Return ->
Value: 4.5
Growth: 7.3
Quality: 5.2
Yield: 0.0
Momentum: 0.0
Volatility: 2.7
1-Year Total Return ->